Suppr超能文献

肠球菌属粪肠球菌全基因组转录应答泰利霉素的分析揭示 CroRS 是抗菌药物耐受的必需调控因子。

Genomewide Profiling of the Enterococcus faecalis Transcriptional Response to Teixobactin Reveals CroRS as an Essential Regulator of Antimicrobial Tolerance.

机构信息

Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.

Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand.

出版信息

mSphere. 2019 May 8;4(3):e00228-19. doi: 10.1128/mSphere.00228-19.

Abstract

Teixobactin is a new antimicrobial of significant interest. It is active against a number of multidrug-resistant pathogens, including and , with no reported mechanisms of teixobactin resistance. However, historically, mechanisms of resistance always exist and arise upon introduction of a new antimicrobial into a clinical setting. Therefore, for teixobactin to remain effective long term, we need to understand how mechanisms of resistance could develop. Here we demonstrate that shows a remarkable intrinsic tolerance to high concentrations of teixobactin. This is of critical importance, as antimicrobial tolerance has been shown to precede the development of antimicrobial resistance. To identify potential pathways responsible for this tolerance, we determined the genomewide expression profile of strain JH2-2 in response to teixobactin using RNA sequencing. A total of 573 genes were differentially expressed (2.0-fold log change in expression) in response to teixobactin, with genes involved in cell wall biogenesis and division and transport/binding being among those that were the most upregulated. Comparative analyses of cell wall-targeting antimicrobial transcriptomes identified CroRS, LiaRS, and YclRK to be important two-component regulators of antimicrobial-mediated stress. Further investigation of CroRS demonstrated that deletion of abolished tolerance to teixobactin and to other cell wall-targeting antimicrobials. This highlights the crucial role of CroRS in controlling the molecular response to teixobactin. Teixobactin is a new antimicrobial with no known mechanisms of resistance. Understanding how resistance could develop will be crucial to the success and longevity of teixobactin as a new potent antimicrobial. Antimicrobial tolerance has been shown to facilitate the development of resistance, and we show that is intrinsically tolerant to teixobactin at high concentrations. We subsequently chose as a model to elucidate the molecular mechanism underpinning teixobactin tolerance and how this may contribute to the development of teixobactin resistance.

摘要

泰妙菌素是一种新的具有重要意义的抗菌药物。它对多种多药耐药病原体具有活性,包括 和 ,并且没有报道其耐药机制。然而,从历史上看,耐药机制总是存在的,并且在将新的抗菌药物引入临床环境时就会出现。因此,为了使泰妙菌素长期保持有效,我们需要了解耐药机制如何发展。在这里,我们证明 对高浓度泰妙菌素表现出显著的固有耐受性。这一点非常重要,因为抗菌药物耐受性已被证明先于抗菌药物耐药性的发展。为了确定导致这种耐受性的潜在途径,我们使用 RNA 测序确定了 菌株 JH2-2 对泰妙菌素的全基因组表达谱。共有 573 个基因的表达发生了差异(表达变化 2.0 倍对数),其中与细胞壁生物发生和分裂以及运输/结合相关的基因是上调最明显的基因之一。对细胞壁靶向抗菌药物转录组的比较分析表明,CroRS、LiaRS 和 YclRK 是抗菌药物介导应激的重要双组分调节剂。对 CroRS 的进一步研究表明, 删除 后消除了对泰妙菌素和其他细胞壁靶向抗菌药物的耐受性。这突出了 CroRS 在控制对泰妙菌素的分子反应中的关键作用。泰妙菌素是一种新的抗菌药物,其耐药机制尚不清楚。了解耐药机制如何发展对于泰妙菌素作为一种新的有效抗菌药物的成功和长期应用至关重要。抗菌药物耐受性已被证明有助于耐药性的发展,我们表明 在高浓度下对泰妙菌素固有耐受。随后,我们选择 作为模型来阐明泰妙菌素耐受性的分子机制,以及这如何导致泰妙菌素耐药性的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ed6/6506618/969fbfa25c86/mSphere.00228-19-f0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验